Literature DB >> 26223505

Control of autoimmune CNS inflammation by astrocytes.

Veit Rothhammer1, Francisco J Quintana2.   

Abstract

Multiple sclerosis is a neurologic disease caused by immune cell infiltration into the central nervous system, resulting in gray and white matter inflammation, progressive demyelination, and neuronal loss. Astrocytes, the most abundant cell population in the central nervous system (CNS), have been considered inert scaffold or housekeeping cells for many years. However, recently, it has become clear that this cell population actively modulates the immune response in the CNS at multiple levels. While being exposed to a plethora of cytokines during ongoing autoimmune inflammation, astrocytes modulate local CNS inflammation by secreting cytokines and chemokines, among other factors. This review article gives an overview of the most recent understanding about cytokine networks operational in astrocytes during autoimmune neuroinflammation and highlights potential targets for immunomodulatory therapies for multiple sclerosis.

Entities:  

Keywords:  Astrocyte; Blood-brain barrier; Chemokine; Cytokine; Multiple sclerosis

Mesh:

Substances:

Year:  2015        PMID: 26223505      PMCID: PMC4618768          DOI: 10.1007/s00281-015-0515-3

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  138 in total

1.  Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation.

Authors:  Fahad Haroon; Katrin Drögemüller; Ulrike Händel; Anna Brunn; Dirk Reinhold; Gopala Nishanth; Werner Mueller; Christian Trautwein; Matthias Ernst; Martina Deckert; Dirk Schlüter
Journal:  J Immunol       Date:  2011-04-22       Impact factor: 5.422

2.  Preferential expression and function of Toll-like receptor 3 in human astrocytes.

Authors:  Cinthia Farina; Markus Krumbholz; Thomas Giese; Gunther Hartmann; Francesca Aloisi; Edgar Meinl
Journal:  J Neuroimmunol       Date:  2004-11-11       Impact factor: 3.478

3.  Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide.

Authors:  Emanuela Colombo; Marco Di Dario; Eleonora Capitolo; Linda Chaabane; Jia Newcombe; Gianvito Martino; Cinthia Farina
Journal:  Ann Neurol       Date:  2014-07-15       Impact factor: 10.422

4.  Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1.

Authors:  A Muhlethaler-Mottet; W Di Berardino; L A Otten; B Mach
Journal:  Immunity       Date:  1998-02       Impact factor: 31.745

5.  Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis.

Authors:  Zizhen Kang; Cengiz Zubeyir Altuntas; Muhammet Fatih Gulen; Caini Liu; Natalia Giltiay; Hongwei Qin; Liping Liu; Wen Qian; Richard M Ransohoff; Cornelia Bergmann; Stephen Stohlman; Vincent K Tuohy; Xiaoxia Li
Journal:  Immunity       Date:  2010-03-18       Impact factor: 31.745

6.  Induction of chemokine and cytokine genes in astrocytes following infection with Theiler's murine encephalomyelitis virus is mediated by the Toll-like receptor 3.

Authors:  Eui Young So; Min Hyung Kang; Byung S Kim
Journal:  Glia       Date:  2006-06       Impact factor: 7.452

7.  Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation.

Authors:  Henrik Wilms; Jobst Sievers; Uta Rickert; Martin Rostami-Yazdi; Ulrich Mrowietz; Ralph Lucius
Journal:  J Neuroinflammation       Date:  2010-05-19       Impact factor: 8.322

8.  Maternal immune activation in late gestation increases neuroinflammation and aggravates experimental autoimmune encephalomyelitis in the offspring.

Authors:  Adriano Zager; Jean Pierre Peron; Gregory Mennecier; Sandra C Rodrigues; Thiago P Aloia; João Palermo-Neto
Journal:  Brain Behav Immun       Date:  2014-08-07       Impact factor: 7.217

9.  Characterization of the interaction between astrocytes and encephalitogenic lymphocytes during the development of experimental autoimmune encephalitomyelitis (EAE) in mice.

Authors:  J F Yang; H Q Tao; Y M Liu; X X Zhan; Y Liu; X Y Wang; J H Wang; L L Mu; L L Yang; Z M Gao; Q F Kong; G Y Wang; J H Han; B Sun; H L Li
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

10.  Resolution of central nervous system astrocytic and endothelial sources of CCL2 gene expression during evolving neuroinflammation.

Authors:  Bandana Shrestha; Shujun Ge; Joel S Pachter
Journal:  Fluids Barriers CNS       Date:  2014-03-04
View more
  67 in total

Review 1.  Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis.

Authors:  Hadi Atabati; Esmaeil Yazdanpanah; Hamed Mortazavi; Saeed Gharibian Bajestani; Amir Raoofi; Seyed-Alireza Esmaeili; Azad Khaledi; Ehsan Saburi; Jalil Tavakol Afshari; Thozhukat Sathyapalan; Abbas Shapouri Moghaddam; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Astrocytes to the rescue! Glia limitans astrocytic endfeet control CNS inflammation.

Authors:  Francisco J Quintana
Journal:  J Clin Invest       Date:  2017-07-24       Impact factor: 14.808

Review 3.  Cytokine networks in neuroinflammation.

Authors:  Burkhard Becher; Sabine Spath; Joan Goverman
Journal:  Nat Rev Immunol       Date:  2016-12-05       Impact factor: 53.106

4.  TNFR2 limits proinflammatory astrocyte functions during EAE induced by pathogenic DR2b-restricted T cells.

Authors:  Itay Raphael; Francisco Gomez-Rivera; Rebecca A Raphael; Rachel R Robinson; Saisha Nalawade; Thomas G Forsthuber
Journal:  JCI Insight       Date:  2019-12-19

5.  A gut feeling about multiple sclerosis.

Authors:  Francisco J Quintana; Marco Prinz
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-25       Impact factor: 11.205

Review 6.  Achievements and obstacles of remyelinating therapies in multiple sclerosis.

Authors:  Martin Stangel; Tanja Kuhlmann; Paul M Matthews; Trevor J Kilpatrick
Journal:  Nat Rev Neurol       Date:  2017-11-17       Impact factor: 42.937

7.  Gestational Hypothyroxinemia Imprints a Switch in the Capacity of Astrocytes and Microglial Cells of the Offspring to React in Inflammation.

Authors:  María C Opazo; Pablo A González; Betsi D Flores; Luis F Venegas; Eduardo A Albornoz; Pablo Cisternas; Karen Bohmwald; Pamela A Nieto; Susan M Bueno; Alexis M Kalergis; Claudia A Riedel
Journal:  Mol Neurobiol       Date:  2017-06-27       Impact factor: 5.590

Review 8.  New Insights into the Role of IL-1β in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.

Authors:  Chih-Chung Lin; Brian T Edelson
Journal:  J Immunol       Date:  2017-06-15       Impact factor: 5.422

9.  Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation.

Authors:  Veit Rothhammer; Jessica E Kenison; Emily Tjon; Maisa C Takenaka; Kalil Alves de Lima; Davis M Borucki; Chun-Cheih Chao; Annabel Wilz; Manon Blain; Luke Healy; Jack Antel; Francisco J Quintana
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-06       Impact factor: 11.205

Review 10.  Brain-immune interactions in perinatal hypoxic-ischemic brain injury.

Authors:  Bo Li; Katherine Concepcion; Xianmei Meng; Lubo Zhang
Journal:  Prog Neurobiol       Date:  2017-10-27       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.